UY32570A - Vacuna viva modificada de mycoplasma bovis mejorada - Google Patents
Vacuna viva modificada de mycoplasma bovis mejoradaInfo
- Publication number
- UY32570A UY32570A UY0001032570A UY32570A UY32570A UY 32570 A UY32570 A UY 32570A UY 0001032570 A UY0001032570 A UY 0001032570A UY 32570 A UY32570 A UY 32570A UY 32570 A UY32570 A UY 32570A
- Authority
- UY
- Uruguay
- Prior art keywords
- mycoplasma bovis
- living vaccine
- modified living
- bovis
- improved
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/35—Mycoplasma
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Wood Science & Technology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17254309P | 2009-04-24 | 2009-04-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY32570A true UY32570A (es) | 2010-11-30 |
Family
ID=42331013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001032570A UY32570A (es) | 2009-04-24 | 2010-04-22 | Vacuna viva modificada de mycoplasma bovis mejorada |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9339533B2 (https=) |
| EP (1) | EP2421556B1 (https=) |
| JP (1) | JP5793808B2 (https=) |
| KR (1) | KR101880888B1 (https=) |
| CN (1) | CN102458461B (https=) |
| AR (1) | AR076413A1 (https=) |
| AU (1) | AU2010238689B2 (https=) |
| BR (1) | BRPI1013836B1 (https=) |
| CA (1) | CA2758733C (https=) |
| CL (1) | CL2011002639A1 (https=) |
| CO (1) | CO6460761A2 (https=) |
| DK (1) | DK2421556T3 (https=) |
| ES (1) | ES2630209T3 (https=) |
| HU (1) | HUE033618T2 (https=) |
| MX (1) | MX342443B (https=) |
| NZ (1) | NZ595914A (https=) |
| PL (1) | PL2421556T3 (https=) |
| SG (2) | SG10201401784WA (https=) |
| UY (1) | UY32570A (https=) |
| WO (1) | WO2010124154A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2121721A4 (en) * | 2006-09-07 | 2010-10-06 | Boehringer Ingelheim Vetmed | GENOTYPING ON PCR BASE |
| CL2008003202A1 (es) * | 2007-10-29 | 2009-11-27 | Boehringer Ingelheim Vetmedica Inc | Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta. |
| AU2009309041B2 (en) | 2008-10-31 | 2016-02-04 | Boehringer Ingelheim Animal Health USA Inc. | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition |
| UY32570A (es) | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
| CA2699024C (en) * | 2009-11-06 | 2016-12-13 | Intervet International B.V. | Methods of immunizing pregnant heifers at three months of gestation |
| CN102294026A (zh) * | 2010-11-17 | 2011-12-28 | 赤峰博恩药业有限公司 | 奶牛链球菌乳房炎灭活疫苗及其制备方法 |
| US9175049B2 (en) * | 2012-10-24 | 2015-11-03 | The United States Of America, As Represented By The Secretary Of Agriculture | Recombinant mycobacterium avium subsp. paratuberculosis proteins induce immunity and protect against infection |
| US10139409B2 (en) | 2013-12-18 | 2018-11-27 | Asahi Kasei Kabushiki Kaisha | Method for detecting Streptococcus bacterium contained in milk |
| CN103800901B (zh) * | 2014-01-27 | 2015-12-09 | 内蒙古华希生物科技有限公司 | 链球菌以及将其灭活得到的奶牛乳房炎疫苗 |
| EP4137152A1 (en) * | 2015-08-14 | 2023-02-22 | Zoetis Services LLC | Mycoplasma bovis compositions |
| CN105441368B (zh) * | 2016-01-19 | 2019-01-01 | 福清市默克兽医院 | 一株牛支原体及其应用 |
| CN107815439A (zh) * | 2016-09-14 | 2018-03-20 | 华威特（江苏）生物制药有限公司 | 牛传染性鼻气管炎病毒jsm株及其应用 |
| CN107759674B (zh) * | 2017-09-26 | 2021-12-28 | 中国农业科学院哈尔滨兽医研究所 | 一种牛支原体免疫相关性蛋白、含有该蛋白的检测试剂盒及其在牛支原体抗体检测中的用途 |
| CN109022314B (zh) * | 2018-08-06 | 2021-08-13 | 北京华夏兴洋生物科技有限公司 | 一株牛支原体及其在疫苗研制中的应用 |
| CN109847060A (zh) * | 2019-04-19 | 2019-06-07 | 黑龙江八一农垦大学 | 牛多杀性巴氏杆菌病、溶血性曼氏杆菌病二联灭活疫苗及其制备方法 |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| CN111733094B (zh) * | 2020-05-29 | 2022-09-09 | 内蒙古民族大学 | 一种牛源蜡样芽孢杆菌及其应用 |
| US12537071B1 (en) | 2020-07-22 | 2026-01-27 | David Gordon Bermudes | Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins |
| AR124849A1 (es) | 2021-02-11 | 2023-05-10 | Intervet Int Bv | Vacuna para mycoplasma bovis |
| CN115869392B (zh) * | 2022-12-12 | 2025-06-24 | 内蒙古华希生物科技有限公司 | 牛病毒性腹泻病毒、传染性鼻气管炎病毒、副流感病毒3型和支原体四联灭活疫苗 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999002670A1 (en) | 1997-07-10 | 1999-01-21 | The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services | Method of attenuating pathogenic mycobacteria and strains of mycobacteria so attenuated |
| EP0965639A1 (en) | 1998-06-05 | 1999-12-22 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| BR0015398A (pt) | 1999-11-08 | 2002-06-25 | Biomune | Vacinas para mycoplasma bovis e processos de uso |
| US6548069B2 (en) | 2001-02-03 | 2003-04-15 | Hmv Associates, Inc. | Multivalent Mycoplasma bacterin |
| US20030147914A1 (en) | 2001-07-02 | 2003-08-07 | Pfizer Inc. | Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
| CN1612749A (zh) | 2001-07-02 | 2005-05-04 | 辉瑞产品公司 | 用于减弱牲畜体内牛支原体肺炎的猪肺炎支原体疫苗和方法 |
| CA2457514A1 (en) | 2001-08-28 | 2003-03-06 | Pfizer Products Inc. | Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions |
| US7217420B2 (en) * | 2002-07-13 | 2007-05-15 | The University Of Georgia Research Foundation, Inc. | Mycoplasma gallisepticum formulation |
| DE102004025452A1 (de) | 2004-05-19 | 2006-01-19 | Boehringer Ingelheim Vetmedica Gmbh | Vakzine enthaltend BVDV |
| US20070009545A1 (en) | 2005-07-07 | 2007-01-11 | Joachim Frey | Mycoplasma subunit vaccine |
| EP2121721A4 (en) | 2006-09-07 | 2010-10-06 | Boehringer Ingelheim Vetmed | GENOTYPING ON PCR BASE |
| CN100419073C (zh) * | 2006-09-28 | 2008-09-17 | 中国兽医药品监察所 | 猪喘气病活疫苗及其生产方法 |
| TW200918666A (en) * | 2007-09-11 | 2009-05-01 | Wyeth Corp | Attenuated mycoplasma gallisepticum strains |
| US20090068231A1 (en) | 2007-09-11 | 2009-03-12 | Wyeth | Live attenuated mycoplasma strains |
| CL2008003202A1 (es) * | 2007-10-29 | 2009-11-27 | Boehringer Ingelheim Vetmedica Inc | Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta. |
| CA2729080C (en) | 2008-07-03 | 2018-09-11 | Ricardo Rosenbusch | Cattle vaccines |
| AU2009309041B2 (en) | 2008-10-31 | 2016-02-04 | Boehringer Ingelheim Animal Health USA Inc. | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition |
| UY32570A (es) | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
-
2010
- 2010-04-22 UY UY0001032570A patent/UY32570A/es active IP Right Grant
- 2010-04-23 AR ARP100101382A patent/AR076413A1/es active IP Right Grant
- 2010-04-23 PL PL10717367T patent/PL2421556T3/pl unknown
- 2010-04-23 SG SG10201401784WA patent/SG10201401784WA/en unknown
- 2010-04-23 MX MX2011010976A patent/MX342443B/es active IP Right Grant
- 2010-04-23 BR BRPI1013836A patent/BRPI1013836B1/pt active IP Right Grant
- 2010-04-23 KR KR1020117024968A patent/KR101880888B1/ko active Active
- 2010-04-23 NZ NZ595914A patent/NZ595914A/en unknown
- 2010-04-23 ES ES10717367.6T patent/ES2630209T3/es active Active
- 2010-04-23 JP JP2012507405A patent/JP5793808B2/ja active Active
- 2010-04-23 AU AU2010238689A patent/AU2010238689B2/en active Active
- 2010-04-23 CN CN201080028660.0A patent/CN102458461B/zh active Active
- 2010-04-23 US US12/766,084 patent/US9339533B2/en active Active
- 2010-04-23 HU HUE10717367A patent/HUE033618T2/en unknown
- 2010-04-23 WO PCT/US2010/032149 patent/WO2010124154A1/en not_active Ceased
- 2010-04-23 DK DK10717367.6T patent/DK2421556T3/en active
- 2010-04-23 SG SG2011077617A patent/SG175323A1/en unknown
- 2010-04-23 EP EP10717367.6A patent/EP2421556B1/en active Active
- 2010-04-23 CA CA2758733A patent/CA2758733C/en active Active
-
2011
- 2011-10-21 CL CL2011002639A patent/CL2011002639A1/es unknown
- 2011-11-11 CO CO11154171A patent/CO6460761A2/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP2421556A1 (en) | 2012-02-29 |
| CL2011002639A1 (es) | 2012-07-20 |
| EP2421556B1 (en) | 2017-04-05 |
| AU2010238689B2 (en) | 2017-01-19 |
| SG175323A1 (en) | 2011-11-28 |
| HUE033618T2 (en) | 2017-12-28 |
| JP2012524548A (ja) | 2012-10-18 |
| US9339533B2 (en) | 2016-05-17 |
| US20100272759A1 (en) | 2010-10-28 |
| BRPI1013836B1 (pt) | 2020-04-14 |
| JP5793808B2 (ja) | 2015-10-14 |
| MX342443B (es) | 2016-09-29 |
| CO6460761A2 (es) | 2012-06-15 |
| SG10201401784WA (en) | 2014-08-28 |
| WO2010124154A1 (en) | 2010-10-28 |
| CA2758733C (en) | 2019-12-24 |
| PL2421556T3 (pl) | 2017-09-29 |
| NZ595914A (en) | 2014-09-26 |
| AU2010238689A1 (en) | 2011-11-03 |
| DK2421556T3 (en) | 2017-07-10 |
| MX2011010976A (es) | 2011-11-18 |
| ES2630209T3 (es) | 2017-08-18 |
| CN102458461B (zh) | 2017-03-08 |
| KR20120109992A (ko) | 2012-10-09 |
| CN102458461A (zh) | 2012-05-16 |
| CA2758733A1 (en) | 2010-10-28 |
| AR076413A1 (es) | 2011-06-08 |
| KR101880888B1 (ko) | 2018-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY32570A (es) | Vacuna viva modificada de mycoplasma bovis mejorada | |
| UY31437A1 (es) | Vacuna de mycoplasma bovis y métodos de uso de la misma | |
| BR112016006589A2 (pt) | composição, e composição de vacina | |
| AR110684A1 (es) | Composiciones que comprenden cepas bacterianas y método de tratamiento | |
| BR112018068593A2 (pt) | composições tópicas não aquosas que compreendem uma salicilanilida halogenada | |
| AR072435A1 (es) | Composicion nutricional para lactantes nacidos por cesarea | |
| WO2011110655A3 (en) | Immunogenic composition or vaccine against gram - negative bacterial, for example neiserial, infection or disease | |
| CO6880050A2 (es) | Composiciones y metodos para controlar la fusariosis | |
| CL2015003120A1 (es) | Cepas bacterianas que poseen actividad antimicrobiana y composiciones de control biológico que las contienen | |
| CL2011002852A1 (es) | Uso de bacterias del acido lactico probioticas por un tratamiento con calor para la preparacion de composiciones para prevenir o tratar inmunodeficiencias causadas por infecciones bacterianas, virales, fungicas y/o parasitarias. | |
| CO6361948A2 (es) | Uso de antigeno de mycoplasma bovis | |
| UY32457A (es) | Vacuna del virus del dengue inactivado | |
| CL2015001562A1 (es) | Método para obtener una vacuna de mycoplasma. | |
| BR112016012599A2 (pt) | composição, e, método para tratamento ou prevenção de uma infecção por staphylococcus aureus | |
| UA98506C2 (en) | Attenuated mycoplasma gallisepticum strains | |
| MX2017016401A (es) | Composiciones inmunogenas. | |
| CL2012002902A1 (es) | Cepas de bacteriofagos especifica contra bacterias pertenecientes al genero vibrio para la profilaxis y terapia de vibrio anguillarum; y composicion antibacteriana que comprende dicha cepas. | |
| PL404229A1 (pl) | Wyizolowany immunogenny antygen bakteryjny i jego zastosowanie w profilaktyce i leczeniu zakażeń wywołanych przez Gram-ujemne bakterie | |
| BR112012021383A2 (pt) | tratamento ou prevencao de infeccao | |
| BR112022005345A2 (pt) | Composições imunogênicas | |
| GB2515222A (en) | Use of flagellin as a vaccine | |
| CL2017001818A1 (es) | Bacteria de ácido láctico y su uso para el tratamiento de mastitis | |
| BR112016030728A2 (pt) | método para tratar ou prevenir uma inflamação induzida por bactérias em um indivíduo, composição imunogênica, composição farmacêutica, uso da composição imunogênica, método para produzir uma composição imunogênica, e, método para tratar ou prevenir uma doença | |
| MX2015005112A (es) | Composicion inmunogenica contra la aeromonas hydrophila. | |
| BR112018074107A2 (pt) | método para a redução da contaminação de ovos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 110 | Patent granted |
Effective date: 20200723 |